Press releases
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Key statistics
As of last trade, Aethlon Medical Inc (EJU0:BER) traded at 0.68, 89.94% above the 52 week low of 0.358 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.63 |
---|---|
High | 0.68 |
Low | 0.62 |
Bid | 0.57 |
Offer | 0.79 |
Previous close | 0.615 |
Average volume | 25.95k |
---|---|
Shares outstanding | 5.05m |
Free float | 4.88m |
P/E (TTM) | -- |
Market cap | 3.50m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of Jun 17 2024 10:58 BST.
More ▼